Development of a Korean‐specific virtual population for physiologically based pharmacokinetic modelling and simulation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of a Korean‐specific virtual population for physiologically based pharmacokinetic modelling and simulation

Published:2019-04 Issue:3-4 Volume:40 Page:135-150
ISSN:0142-2782
Container-title:Biopharmaceutics & Drug Disposition
language:en
Short-container-title:Biopharm Drug Dispos

Author:

Kim Yun¹^ORCID,Hatley Oliver²,Rhee Su‐jin¹,Yi Sojeong¹,Lee Hyun A.¹³,Yoon Sumin¹,Chung Jae‐Yong⁴,Yu Kyung‐Sang¹,Lee Howard¹³

Affiliation:

1. Department of Clinical Pharmacology and TherapeuticsSeoul National University College of Medicine and Hospital Seoul South Korea

2. Simcyp DivisionCertara UK Limited UK

3. Department of Transdisciplinary Studies, Graduate School of Convergence Science and TechnologySeoul National University Seoul South Korea

4. Department of Clinical Pharmacology and TherapeuticsSeoul National University College of Medicine and Bundang Hospital Seongnam South Korea

Funder

Korea Health Industry Development Institute

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/bdd.2178

Reference61 articles.

1. Effect of nebicapone on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects;Almeida L.;European Journal of Clinical Pharmacology,2008

2. Differences in cytochrome p450‐mediated pharmacokinetics between Chinese and Caucasian populations predicted by mechanistic physiologically based pharmacokinetic modelling;Barter Z. E.;Clinical Pharmacokinetics,2013

3. Impact of ABCG2 and SLCO1B1 polymorphisms on pharmacokinetics of rosuvastatin, atorvastatin and simvastatin acid in Caucasian and Asian subjects: a class effect?;Birmingham B. K.;European Journal of Clinical Pharmacology,2015

4. Rosuvastatin pharmacokinetics and pharmacogenetics in Caucasian and Asian subjects residing in the United States;Birmingham B. K.;European Journal of Clinical Pharmacology,2015

5. Effect of the potent CYP2D6 inhibitor sarpogrelate on the pharmacokinetics and pharmacodynamics of metoprolol in healthy male Korean volunteers;Cho D. Y.;Xenobiotica,2015

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Warfarin–A natural anticoagulant: A review of research trends for precision medication;Phytomedicine;2024-06

2. Physiologically Based Pharmacokinetic Model To Predict Metoprolol Disposition in Healthy and Disease Populations;ACS Omega;2023-08-03

3. Performance Verification of CYP2C19 Enzyme Abundance Polymorphism Settings within the Simcyp Simulator v21;Metabolites;2022-10-20

4. Case Study on Certara’s Simcyp PBPK Simulator to Eliminate Lengthy Clinical Trails;International Journal of Health Sciences and Pharmacy;2022-10-12

5. Model-Based Prediction of Acid Suppression and Proposal of a New Dosing Regimen of Fexuprazan in Humans;Pharmaceuticals;2022-06-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3